BRAIDWELL LP
Adviser information for BRAIDWELL LP last updated from Form ADV on March 28th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
Type of Organization | Limited Partnership |
---|---|
Fiscal Year End | DECEMBER |
Legal Location | Delaware, United States |
Employees
Total Number of Employees | 38 |
---|---|
Investment Advisory/Research | 20 |
Registered Broker-Dealer Representatives | 0 |
Registered State Investment Advisers | 0 |
Licensed Agents of an Insurance Company | 0 |
No. of Firms/People that Solicit Clients | 0 |
RAUM
Provides Management of Securities Portfolios | Yes |
---|
Type | Accounts | RAUM |
---|---|---|
Discretionary | 8 | $4.9B |
Non-Discretionary | 0 | $0 |
Total | 8 | $4.9B |
Clients
Type | Number | RAUM |
---|---|---|
Individuals | 0 | $0 |
HNW Individuals | 0 | $0 |
Banking or thrift institutions | 0 | $0 |
Investment companies | 0 | $0 |
Business development companies | 0 | $0 |
Pooled investment vehicles | 8 | $4.9B |
Pension and profit sharing plans | 0 | $0 |
Charitable organizations | 0 | $0 |
State or municipal gov entities | 0 | $0 |
Other investment advisers | 0 | $0 |
Insurance companies | 0 | $0 |
Sovereign wealth funds and foreign official institutions | 0 | $0 |
Corporations or other businesses | 0 | $0 |
Other | 0 | $0 |
Type | Number |
---|---|
No. of Non-RAUM Clients | 0 |
No. of Non-U.S. Clients | 50 |
Services
Advisory Services | Portfolio management for pooled investment vehicles |
---|---|
Compensation | % of AUMPerformance-based fees |
Principal Office
ONE HARBOR POINT, 2200 ATLANTIC STREET4TH FLOOR
STAMFORD
CT
United States
Monday - Friday, 8:00AM-5:00PM
Tel: 866-453-3929, Fax: None
Chief Compliance Officer
MANISH MITAL
ONE HARBOR POINT, 2200 ATLANTIC STREET
4TH FLOOR
STAMFORD
CT
United States
Tel:
866-453-3929
M*****@************M
(Full email address available in API data)
Industry Affiliates
BRAIDWELL GP LLC | Other investment adviser, including financial plannersCommodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles |
Private Funds
Name | Type | Assets $USD | Min Investment $USD | No. Owners |
---|---|---|---|---|
BRAIDWELL COMPANION CMV (US) LP - 2023-1 SERIES | Hedge Fund | $44.9M | $5.0M | 9 |
BRAIDWELL COMPANION CMV LP | Hedge Fund | $26.8M | $5.0M | 2 |
BRAIDWELL COMPANION CMV MASTER FUND LP | Hedge Fund | $8.8M | $5.0M | 11 |
BRAIDWELL COMPANION CMV TRANSACTION MASTER FUND LP | Hedge Fund | $13.5M | $5.0M | 11 |
BRAIDWELL PARTNERS (US) LP | Hedge Fund | $1,224.9M | $5.0M | 96 |
BRAIDWELL PARTNERS LP | Hedge Fund | $2,474.1M | $5.0M | 72 |
BRAIDWELL PARTNERS MASTER FUND LP | Hedge Fund | $3,274.5M | $5.0M | 168 |
BRAIDWELL PARTNERS TRANSACTION MASTER FUND LP | Hedge Fund | $424.5M | $5.0M | 168 |
Control Persons
Name | Type | Entity | Title | Since | Ownership |
---|---|---|---|---|---|
MITAL, MANISH, KUMAR | Individual | – | CHIEF OPERATING OFFICER/GENERAL COUNSEL/CHIEF COMPLIANCE OFFICER | 08/2021 | < 5% |
KREITER, BRIAN, JAMES | Individual | – | CO-FOUNDER/CEO | 08/2021 | < 5% |
KARNAL, ALEXANDER, THOMAS | Individual | – | CO-FOUNDER/CIO | 08/2021 | < 5% |
BRAIDWELL MANAGEMENT LLC | Domestic Entity | – | GENERAL PARTNER | 08/2021 | < 5% |
BRAIDWELL HOLDINGS LP | Domestic Entity | – | LIMITED PARTNER | 08/2021 | > 75% |
KARNAL, ALEXANDER, THOMAS | Individual | BRAIDWELL MANAGEMENT LLC | MANAGING MEMBER | 01/2021 | 50-75% |
KREITER, BRIAN, JAMES | Individual | BRAIDWELL MANAGEMENT LLC | MANAGING MEMBER | 01/2021 | 25-50% |
BRAIDWELL MANAGEMENT LLC | Domestic Entity | BRAIDWELL HOLDINGS LP | GENERAL PARTNER | 01/2021 | |
KARNAL, ALEXANDER, THOMAS | Individual | BRAIDWELL HOLDINGS LP | LIMITED PARTNER | 01/2021 | 50-75% |
KREITER, BRIAN, JAMES | Individual | BRAIDWELL HOLDINGS LP | LIMITED PARTNER | 01/2021 | 25-50% |
No. Employees, Historic
RAUM, Historic
No. Clients, Historic
Holdings
From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
Name | Class | Value $USD | # Shares | Private Fund |
---|---|---|---|---|
4D MOLECULAR THERAPEUTICS IN | COM | 8M | 369K | – |
89BIO INC | COM | 1M | 164K | – |
AKERO THERAPEUTICS INC | COM | 25M | 1M | – |
ALECTOR INC | COM | 11M | 2M | – |
ALIGN TECHNOLOGY INC | COM | 66M | 275K | – |
ALPHATEC HLDGS INC | COM NEW | 23M | 2M | – |
ALPHATEC HLDGS INC | NOTE 0.750% 8/0 | 57M | – | – |
APELLIS PHARMACEUTICALS INC | COM | 23M | 612K | – |
APOGEE THERAPEUTICS INC | COM | 94M | 2M | – |
ARGENX SE | SPONSORED ADR | 72M | 167K | – |
ARVINAS INC | COM | 14M | 517K | – |
AVADEL PHARMACEUTICALS PLC | COM SHS | 41M | 3M | – |
BRIDGEBIO PHARMA INC | COM | 9M | 346K | – |
BRIDGEBIO PHARMA INC | NOTE 2.250% 2/0 | 52M | – | – |
BRIDGEBIO PHARMA INC | NOTE 2.500% 3/1 | 143M | – | – |
CASTLE BIOSCIENCES INC | COM | 9M | 416K | – |
CELCUITY INC | COM | 8M | 517K | – |
CG ONCOLOGY INC | COM | 104M | 3M | – |
CONMED CORP | NOTE 2.250% 6/1 | 4M | – | – |
CULLINAN THERAPEUTICS INC | COM | 3M | 176K | – |
CUTERA INC | NOTE 4.000% 6/0 | 5M | – | – |
CUTERA INC | NOTE 2.250% 6/0 | 5M | – | – |
DAY ONE BIOPHARMACEUTICALS I | COM | 42M | 3M | – |
DBV TECHNOLOGIES S A | SPONSORED ADR | 2M | 2M | – |
DEXCOM INC | NOTE 0.375% 5/1 | 81M | – | – |
DEXCOM INC | NOTE 0.250%11/1 | 74M | – | – |
DIANTHUS THERAPEUTICS INC | COM | 9M | 367K | – |
ELEVATION ONCOLOGY INC | COM | 7M | 2M | – |
EXACT SCIENCES CORP | COM | 48M | 1M | – |
GLAUKOS CORP | COM | 59M | 497K | – |
GUARDANT HEALTH INC | COM | 81M | 3M | – |
GUARDANT HEALTH INC | NOTE11/1 | 208M | – | – |
HAEMONETICS CORP MASS | NOTE3/0 | 10M | – | – |
HARROW INC | COM | 6M | 297K | – |
IMMUNOCORE HLDGS PLC | ADS | 27M | 797K | – |
INSPIRE MED SYS INC | COM | 51M | 379K | – |
INSULET CORP | NOTE 0.375% 9/0 | 74M | – | – |
INTUITIVE SURGICAL INC | COM NEW | 45M | 101K | – |
IOVANCE BIOTHERAPEUTICS INC | COM | 12M | 1M | – |
IRHYTHM TECHNOLOGIES INC | COM | 57M | 526K | – |
IRONWOOD PHARMACEUTICALS INC | COM CL A | 29M | 4M | – |
IRONWOOD PHARMACEUTICALS INC | NOTE 1.500% 6/1 | 85M | – | – |
KEROS THERAPEUTICS INC | COM | 45M | 982K | – |
KINIKSA PHARMACEUTICALS INTL | ORD SHS CL A | 38M | 2M | – |
KRYSTAL BIOTECH INC | COM | 20M | 107K | – |
LEGEND BIOTECH CORP | SPONSORED ADS | 74M | 2M | – |
LEXEO THERAPEUTICS INC | COM | 22M | 1M | – |
LEXICON PHARMACEUTICALS INC | COM NEW | 14M | 8M | – |
LIVANOVA PLC | SHS | 10M | 174K | – |
LONGBOARD PHARMACEUTICALS IN | COM | 6M | 206K | – |
MARAVAI LIFESCIENCES HLDGS I | COM CL A | 65M | 9M | – |
NEOGENOMICS INC | NOTE 0.250% 1/1 | 91M | – | – |
NEUROCRINE BIOSCIENCES INC | COM | 104M | 759K | – |
NEVRO CORP | COM | 14M | 2M | – |
NOVOCURE LTD | NOTE11/0 | 130M | – | – |
NUVASIVE INC | NOTE 0.375% 3/1 | 110M | – | – |
OCULAR THERAPEUTIX INC | COM | 11M | 2M | – |
ORTHOPEDIATRICS CORP | COM | 32M | 1M | – |
OUTSET MED INC | COM | 3M | 695K | – |
PARAGON 28 INC | COM | 28M | 4M | – |
PENUMBRA INC | COM | 38M | 213K | – |
PULMONX CORP | COM | 5M | 753K | – |
RELAY THERAPEUTICS INC | COM | 20M | 3M | – |
REPLIGEN CORP | COM | 41M | 324K | – |
REPLIMUNE GROUP INC | COM | 9M | 1M | – |
SAREPTA THERAPEUTICS INC | COM | 13M | 82K | – |
SAREPTA THERAPEUTICS INC | NOTE 1.250% 9/1 | 56M | – | – |
SPYRE THERAPEUTICS INC | COM NEW | 59M | 3M | – |
THE BEAUTY HEALTH COMPANY | COM CL A | 10M | 5M | – |
THERMO FISHER SCIENTIFIC INC | COM | 39M | 70K | – |
TRANSMEDICS GROUP INC | COM | 29M | 190K | – |
TRAVERE THERAPEUTICS INC | NOTE 2.500% 9/1 | 49M | – | – |
VAXCYTE INC | COM | 61M | 808K | – |
VIKING THERAPEUTICS INC | COM | 59M | 1M | – |
XENON PHARMACEUTICALS INC | COM | 100M | 3M | – |